智能纳米载体用于治疗视网膜疾病
Shuya Liu1, Zhike Yan1, Zixiang Huang1
1MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, College of Chemistry, Fuzhou University, Fuzhou 350116, P. R. China.
ACS applied bio materials
|March 15, 2024
概括
智能纳米载体为视网膜疾病提供了改善的药物输送,克服了眼睛障碍. 这些先进的系统有望提高控制,效率和安全性,用于治疗诸如黄斑变性和糖尿病视网膜病变等疾病.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 视网膜疾病是全球不可逆转失明的主要原因.
- 目前的药物输送方法面临着由于眼障碍和效率有限的挑战.
- 传统的纳米载体在视网膜应用中往往缺乏可控性,效率和安全性.
研究的目的:
- 审查常见的视网膜病理和药物治疗方法.
- 对视网膜疾病的智能纳米载体设计的最新进展进行调查.
- 讨论挑战,并激发智能纳米载体临床视网膜治疗的未来发展.
主要方法:
- 对视网膜疾病和药物输送系统的文献综述.
- 对视网膜应用的智能纳米载体策略的分析.
- 讨论智能纳米载体临床转化中的挑战.
主要成果:
- 智能纳米载体展示了针对药物输送,长期释放和局部管理的潜力.
- 智能设计利用特定的触发器来增强治疗功能.
- 最近的战略重点是克服传统纳米载体的局限性.
结论:
- 智能纳米载体代表了先进视网膜疾病治疗的前沿前沿.
- 需要进一步的研究来应对成功临床翻译的挑战.
- 智能纳米载体设计具有更有效,更安全的长期视网膜治疗的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


